Development and Application of a Precision Cell-Free DNA (cfdna) Minimal Residual Disease (MRD) Test to Enable Optimized Treatment Selection in Patients with Genitourinary (GU) Cancers.
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要